Cannabinoid Receptor 1 Inhibition in Chronic Kidney Disease: A New Therapeutic Toolbox

Overview of attention for article published in Frontiers in endocrinology, July 2021

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (62nd percentile)
Good Attention Score compared to outputs of the same age and source (74th percentile)

Mentioned by

twitter: 4 X users

peer_reviews: 1 peer review site

Readers on

mendeley: 29 Mendeley

Summary X Peer reviews

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 8,778 followers.

RT @CEOCorbus: Really worthwhile review of the role of CB1 in the kidney. @TamYossi also wrote an excellent one in 2020. Lots to explore a…

13 Oct 2021

Reply Repost Favourite

Absolutely agree.

13 Oct 2021

Reply Repost Favourite

Really worthwhile review of the role of CB1 in the kidney. @TamYossi also wrote an excellent one in 2020. Lots to explore around this CKD/ECS nexus. https://t.co/275whzopJj

13 Oct 2021

Reply Repost Favourite

New Research: Cannabinoid Receptor 1 Inhibition in Chronic Kidney Disease: A New Therapeutic Toolbox: Chronic kidney disease (CKD) concerns millions of individuals worldwide, with few therapeutic strategies available to date. Recent… https://t.co/RSVvgndIp

07 Jul 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.